(PRWEB) August 6, 2004
Technologies in disc replacement have been under development for years and are already available in Europe with the intent of correcting the structural defects in disc disease in a more dynamic manner. This allows more natural functioning of the spine than results from spine fusion.
ÂTotal disc replacement or replacement of just the disc nucleus with an artificial or even tissue-engineered implant has already been well demonstrated in Europe with roughly 7,000 patients implanted with the CharitÃ© disc, now available through DePuy Spine,Â says Patrick Driscoll, publisher of MedMarkets. ÂThis market is also primed to open up, with the third generation version, the CharitÃ© III, likely to gain approval and enter the U.S. market this year, to be followed in the next few years by introduction of replacement disc products from Synthes-Stratec, Medtronic Sofamor Danek, SpineCore, Cervitech, and EBI/Biomet.Â
According to the coverage of disc arthroplasty in the July 2004 MedMarkets, replacement of disc nucleus is not that far behind. The most experienced competitor in development of nucleus implants, Raymedica, began clinical trials in October 2003, and is working toward market introduction in the U.S. by 2007. Products to follow RaymedicaÂs will include the nucleus replacement discs of Disc Dynamics, DePuy Spine, Replication Medical, Spine Wave and Synthes-Stratec by 2009.
The MedMarkets article reviews the competitors, products, and forecast market and its opportunities for disc arthroplasty. In turn, the MedMarkets article provides a glimpse into the broader market for spine surgery technologies publishing from MedMarket Diligence. That report, ÂSpine Surgery: Products, Technologies, Markets & Opportunities, Worldwide,Â is described at http://www.mediligence.com/rpt-m501.htm.
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the ÂMedMarketsÂ newsletter, a monthly analysis of the market implications of new medical technology and dedicated reports on technology markets.
For more information on MedMarket Diligence, LLC,
Patrick Driscoll at (949) 859-3401
e-mail [email protected]
# # #